# HBM Genomics

HBM Genomics is a Private Equity based in San Francisco, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** San Francisco, United States
- **Region:** North America
- **Address:** San Francisco, CA, United States
- **Founded:** 2014
- **Assets under management:** Undisclosed
- **Website:** https://www.hbmgenomics.com
- **LinkedIn:** linkedin.com/company/hbm-genomics

## Regulatory record

- **Reports private funds:** No

## About

HBM Genomics is a life sciences investment firm founded in 2014 in Palo Alto, California. It invests in early-stage companies and partners with founders on strategy, hiring, funding, and scaling. HBM Genomics has made eight investments, including a Series A investment in Galatea Bio on March 27, 2025.

## Sectors

- Digital Health
- Healthcare Services
- AI/ML
- Enterprise Software

## Questions

### Which sectors does HBM Genomics explicitly avoid?

Publicly available information does not specify excluded sectors, but the firm concentrates exclusively on genomics, AI/ML in life sciences, and digital health, implying it avoids general industrial tech, real estate, or consumer-facing ventures.

### Where is HBM Genomics based, and does it have additional offices?

The firm is headquartered in San Francisco, California. No additional office locations have been publicly disclosed.

## Related profiles

- [HB Investment Partners](https://altss.com/profile/hb-investment-partners)
- [HBT Holdings](https://altss.com/profile/hbt-holdings)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/hbm-genomics

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology